Welcome to the newsroom archive
of AOP Health
Please find below archived press releases
Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via firstname.lastname@example.org
AOP Orphan Pharmaceuticals presents latest analysis on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia vera at the prestigious American Society of Hematology (ASH) 2021 Annual Meeting
14. 12. a. m.
BESREMi® (Ropeginterferon alfa-2b) approved by the US FDA
15. 11. a. m.
Can European Solutions Allow Equal Access to Rare Disease Drugs in All European Countries?
6. 10. a. m.
Austrian AOP Orphan to Tap into U.S. Market with Partner Eagle Pharmaceuticals
28. 9. a. m.
AOP Orphan Announces Leadership Changes to Advance Long Term Strategic Direction
27. 8. a. m.
AOP Orphan Pharmaceuticals presents latest analysis on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia vera at the prestigious European Hematology Association (EHA) Annual Meeting 2020
1. 7. a. m.